Your email preview

Greetings, Sloan/MIT Healthcare Community!

We're wrapping up the semester! A couple quick announcements:
1) We want to make the club better! Please fill out this 4-question anonymous survey here.
2) The Martin Trust Center is looking for a new Healthcare Sector Practice Leader. Description is attached, apply here.

As always, we want to hear from you! Send us an email at healthcare.officers@sloangroups.mit.edu with questions, comments, thoughts or feedback - or if you have been up to anything in the healthcare space!

Sheryl, Gokul, and Osaze
Healthcare Club Co-Presidents

Highlights

Last Week's Events
Lunch & Learn with Shan Wu, Assoc. Director of Business Development at Magenta Therapeutics (April 22)
Black Women's Maternal Health: Understanding the Disparities Influencing High Maternal Mortality Rates (April 23)
Healthcare Microhack hosted by MIT, Harvard, and Beth Israel Deaconess Medical Center (April 25)
Spring Healthcare Career Trek (April 26)
Movie Night: Theranos Film and Discussion (April 28)

Events

MIT Analytics Speaker Series - Healthcare Startup Panel
April 30, 12-1pm, E62-233
RSVP
For its last event of the semester, the MIT Analytics Speaker Series is glad to welcome three great startups that use artificial intelligence to revolutionize healthcare. Our speakers will show how various types of data (numerical data, voice recordings, and images) can be harnessed using machine and deep learning to help doctors and improve patients’ lives. Each startup will present a technical case study of their work in the healthcare industry, from data, to models, to decisions. Lunch will be provided.

Pathways to Success for Medical Innovators
May 2, 4-7pm, Nutter McClennen & Fish LLP,155 Seaport Blvd, Boston, Massachusetts 02210
https://www.mdgboston.org/event/Early_Stage_Companies
This forum will bring together a diverse and experienced panel to discuss strategies for startup conception, funding, development and partnership.

Emerging Frontiers in Oncology Summit
May 8th, 2:30pm-8:30pm, 300 Technology Square Cambridge, MA 02139
Join a select group of thought leaders, biotech execs, investors, and entrepreneurs in the Boston community to discuss and debate the drivers of future breakthroughs in oncology across research, innovation and people.
This event is for top-tier investors, executives and PI’s, however, a limited set of tickets are being released for graduate students. Alternatively, students have the opportunity to volunteer at the start of the event (2:30-6:30) and attend the networking session for free. Kindly note this premier event is also a fundraiser for Luke Timmerman’s Kilimanjaro Climb to Fight Cancer.
More Info

Lunch with Charlie Choi ’92 ME, CEO of Axia Women’s Health and former VP at DaVita/Cardinal Health
May 13, 11:45am, MTC Garage
Charlie Choi is an alum interested in connecting with and mentoring your entrepreneurs or students generally interested in intrapreneurship within organizations in the space of healthcare investment/delivery. He is currently the CEO of Axia Women’s Health, a regionally-based network of women’s health clinics, group practices and labs. Previously, he was a VP at DaVita, managing a $1.5B P&L for their dialysis business and at Cardinal Health where he managing the hospital supply business. If you’re interested in attending a lunch meet-and-greet, hosted at MTC on Monday May 13th, please reach out to Stephanie Rampello (rampello@mit.edu).

Business of Biotechnology: Advanced Concepts Short Course
Presented by RA Capital
June 18-27, 2019
Deadline to Apply: May 15, 2019 (midnight)
Apply here

Jobs and Internships

Please be sure to check Career Central for a full list of upcoming company events!

Tenet Healthcare Summer Intern
Opportunity Type: Full-time summer intern
Contact: Lisa Foo, Tenet's Chief Commercial and Strategy Officer (lysfoo@alum.mit.edu)

Business Planning
- Support strategic planning process for Hospital, Physician Organization and Ambulatory
- Analyze market and internal data to identify growth opportunities
- Assess major projects (including network expansion, clinical program development), in collaboration with market leaders
- Participate in annual business planning review with senior business unit leaders
- Based in Dallas – candidates must be proficient in excel and analytics

Strategic Initiatives
- Support end-to-end opportunity assessment for an enterprise strategic initiatives (such as telehealth strategy)
- Assess external market capabilities, define strategic options and conduct cost / benefit assessment
- Facilitate working sessions with clinical advisory groups
- Lead business plan development and own pro forma modeling with input from Finance leadership
- Based in Dallas – candidates must be proficient in excel and analytics

PhAST Internship
Opportunity Type: Full-time summer intern

PhAST is a Boston-based seed-stage AI healthcare company using fully-owned computer vision technology for rapid antibiotic resistance detection in hours instead of days. The company was founded by an MIT PhD alumnus and professor in Engineering, starting pharma R&D for utilizing PhAST’s AI platform for drug development applications, and now raising an $8M series A to perform pilot studies with Boston’s Partners HealthCare institutions. See attached for more details!

Biogen MBA Internship Program
Opportunity Type: Commercial MBA Internship Program, Strategic Pricing, Market Access & Reimbursement
Apply via Career Central

This position within Biogen’s Market Access & Reimbursement group is an opportunity for an analytically-minded MBA student to learn about strategic pricing projects for new and existing therapies. This individual will also learn about market access and payer perceptions in the MS therapy category as well as emerging neurological disease areas. See attached for more details!

Portola Pharmaceuticals
Opportunity Type: Summer Internship, Global Marketing
Apply via Career Central

Portola Pharmaceuticals is a commercial-stage biopharmaceutical company, based in South San Francisco, focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases. Portola has an FDA-approved medicine, Andexxa®, the first and only antidote for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. The company is also advancing cerdulatinib, a Syk/JAK inhibitor for the treatment of hematologic cancers.

General Description:
A Portola internship can be a key experience for a student or recent graduate interested in healthcare or the pharma/biotech industry. The MBA Marketing Summer Internship is a paid, 10-week program based at our South San Francisco headquarters. During the course of the summer, the intern will gain invaluable product and disease-state marketing experience, an opportunity to have a direct business impact, and an understanding of the Portola organization.
Interns will kick-off their summer internship with initial learning/training on the disease-state and therapy.

D-Prize Global Competition
Opportunity Type: Competition
Timeline & Deadline: The competition is live. The deadline is June 2nd (with an extension deadline of June 23rd available for those who sign-up).
https://d-prize.org/?utm_content=Round1_General+%28live%29

Are you ready? The first D-Prize Global Competition of 2019 is LIVE and accepting applications from aspiring social entrepreneurs around the world! D-Prize challenges bold new leaders to tackle distribution problems impeding development in countries where extreme poverty exists. This year, we are looking to award 30 teams with up to $20,000 each to launch nonprofits or social ventures that can distribute proven poverty interventions to thousands, maybe even millions of people. The competition includes several challenges that focus on global health.

LEAPS Project Data Analyst Researcher (MIT NEWDIGS)
Opportunity Type: Temporary- Full or Part-time position - Data Analyst Researcher
Info: www.newdigs.mit.edu
Contact: klarholt@mit.edu

The LEAPS Project is advancing the mission of the MIT NEWDIGS consortium through a new collaborative systems approach to the planning, generation, and use of evidence across R&D and healthcare delivery. A model system for Rheumatoid Arthritis will be piloted in Massachusetts (2020 launch), and will inform related efforts in other diseases and geographies. Success in LEAPS targets better patient outcomes while also reducing waste and inefficiency across the system. We are looking for a Data Analyst researcher to complete this research project by September 1, 2019.

Additional information about this position is attached. Position is open and available to start immediately- full or part-time depending on availability and experience. Send resume and cover letter to Kay Larholt: klarholt@mit.edu.

Pulmonx Product Marketing Manager
Opportunity Type: Full-tiime
Contact: Beran Rose, MBA ’01 brose@pulmonx.com, Marcee Maroney (hiring manager) mmaroney@pulmonx.com

Pulmonx is looking to hire a Product Marketing Manager. The role is a hybrid between market development and product management. The person in the job will play a key role in both physician education and direct to patient advertising, as well as working with the sales team and customers to inform new product and sales tool development.

We have a novel treatment that was recently approved by the FDA and are scaling operations in the USA; we expect to take the company public at the end of this year or start of next year. Our investors include leaders such as Kleiner Perkins, De Novo, Kaiser Permanente and Boston Scientific.

If you’d like to be considered for the role, please email your resume to Beran Rose, MBA ’01 (brose@pulmonx.com) and Marcee Maroney, the hiring manager (mmaroney@pulmonx.com).

DeepHealth Market Research and Product Strategy Intern
Opportunity Type: Summer Internship
Application: Apply via Career Central

Vida Ventures Fellowship Program
Opportunity Type: Fellowship Program
Info: www.vidaventures.com
Contact: jaideep@vidaventures.com

Vida Ventures is a bicoastal life sciences company-building and investment firm focused on breakthrough therapeutics companies. Our mission is to build and fund transformational innovations that have the potential to make a meaningful difference for patients. We want to do well by doing good for others. Vida was founded in 2017 by a group of experienced scientists, physicians, entrepreneurs, and investors. We currently manage $295 million. We are a lean, high-energy team passionate about helping shape the future of medicine and alleviating human suffering. If you share a similar mission, we would love to meet!

Resources

Thank you to our sponsors!